| Today's News and Trends | The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing. The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing. | | |
| Deepak Bhatt, MD, believes bentracimab could be a game-changer if it gains approval. "I think it's the sort of drug that every emergency room and ICU would have to stock," he said. "A cardiac care unit would have to stock a couple of doses, as would every cath lab." Deepak Bhatt, MD, believes bentracimab could be a game-changer if it gains approval. "I think it's the sort of drug that every emergency room and ICU would have to stock," he said. "A cardiac care unit would have to stock a couple of doses, as would every cath lab." | | |
| HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time. HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time. | | |
| The goal is to measure changes in a patient’s IVC area and collapsibility, which can help anticipate when heart failure events might occur. This first-in-human study included data from the first 50 patients to receive the device. The goal is to measure changes in a patient’s IVC area and collapsibility, which can help anticipate when heart failure events might occur. This first-in-human study included data from the first 50 patients to receive the device. | | |
| | TAVR is being used in more patients to treat severe aortic stenosis. However, according to a new commentary piece, SAVR is still the smartest treatment option for certain populations, including younger patients with bicuspid aortic valves. TAVR is being used in more patients to treat severe aortic stenosis. However, according to a new commentary piece, SAVR is still the smartest treatment option for certain populations, including younger patients with bicuspid aortic valves. | | |
| The Sapien M3 device was designed to treat symptomatic mitral regurgitation in patients who are not suitable candidates for surgery or transcatheter edge-to-edge repair. The Sapien M3 device was designed to treat symptomatic mitral regurgitation in patients who are not suitable candidates for surgery or transcatheter edge-to-edge repair. | | |
| SCAI President James B. Hermiller, Jr., MD, detailed the group's key policy concerns in 2025 and beyond in a new video interview. SCAI President James B. Hermiller, Jr., MD, detailed the group's key policy concerns in 2025 and beyond in a new video interview. | | |
| | The agency warned that any unused devices should be removed from the market and returned to the manufacturer. The agency warned that any unused devices should be removed from the market and returned to the manufacturer. | | |
| Aortic valve replacement is likely inevitable for patients with asymptomatic severe aortic stenosis. Immediately performing TAVR or SAVR, however, may not always be the answer. Aortic valve replacement is likely inevitable for patients with asymptomatic severe aortic stenosis. Immediately performing TAVR or SAVR, however, may not always be the answer. | | |
| Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago. Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago. | | |
| | John R. Manning, MD, pleaded guilty to conspiracy to commit healthcare fraud for issuing unnecessary prescriptions billed to Medicare and receiving more than $812,000 in kickbacks. John R. Manning, MD, pleaded guilty to conspiracy to commit healthcare fraud for issuing unnecessary prescriptions billed to Medicare and receiving more than $812,000 in kickbacks. | | |
| According to new projections, the nearly 100 million CT scans conducted in the U.S. during 2023 will result in approximately 103,000 future cancer diagnoses annually due to radiation exposure alone. According to new projections, the nearly 100 million CT scans conducted in the U.S. during 2023 will result in approximately 103,000 future cancer diagnoses annually due to radiation exposure alone. | | |
| |
|
| ![]() | |
|
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-09/istock-1209664264.jpg?itok=d9hdApI9)
